These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 119274)

  • 1. Severe aggression in rats induced by mescaline but not other hallucinogens.
    Sbordone RJ; Wingard JA; Gorelick DA; Elliott ML
    Psychopharmacology (Berl); 1979; 66(3):275-80. PubMed ID: 119274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of lysergic acid diethylamide and mescaline-derived hallucinogens on sensory-integrative function: tactile startle.
    Geyer MA; Petersen LR; Rose GJ; Horwitt DD; Light RK; Adams LM; Zook JA; Hawkins RL; Mandell AJ
    J Pharmacol Exp Ther; 1978 Dec; 207(3):837-47. PubMed ID: 731434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral effects of intracerebroventricular administration of LSD, DOM, mescaline or lisuride.
    Mokler DJ; Rech RH
    Pharmacol Biochem Behav; 1984 Aug; 21(2):281-7. PubMed ID: 6483939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mescaline produces pathological aggression in rats regardless of age or strain.
    Sbordone RJ; Wingard JA; Elliott MK; Jervey J
    Pharmacol Biochem Behav; 1978 May; 8(5):543-6. PubMed ID: 566933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced ataxia in opponents elicits "pathological" fighting in undrugged rats exposed to footshock.
    Elliott ML; Sbordone RJ
    Pharmacol Biochem Behav; 1982 Jan; 16(1):63-6. PubMed ID: 7199187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of some hallucinogens on aggressiveness of mice and rats. I.
    Rewerski W; Kostowski W; Piechocki T; Rylski M
    Pharmacology; 1971; 5(5):314-20. PubMed ID: 5104429
    [No Abstract]   [Full Text] [Related]  

  • 7. Neurotransmitter basis of the behavioral effects of hallucinogens.
    Rech RH; Commissaris RL
    Neurosci Biobehav Rev; 1982; 6(4):521-7. PubMed ID: 6817241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of psilocin with psilocybin, mescaline and LSD-25.
    WOLBACH AB; MINER EJ; ISBELL H
    Psychopharmacologia; 1962; 3():219-23. PubMed ID: 14007905
    [No Abstract]   [Full Text] [Related]  

  • 9. Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.
    Rickli A; Moning OD; Hoener MC; Liechti ME
    Eur Neuropsychopharmacol; 2016 Aug; 26(8):1327-37. PubMed ID: 27216487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psilocybin as a discriminative stimulus: lack of specificity in an animal behavior model for 'hallucinogens'.
    Koerner J; Appel JB
    Psychopharmacology (Berl); 1982; 76(2):130-5. PubMed ID: 6805022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysergic acid diethylamide- and mescaline-induced attenuation of the effect of punishment in the rat.
    Schoenfeld RI
    Science; 1976 May; 192(4241):801-3. PubMed ID: 1063447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of psychodysleptics on aggressive behavior of animals.
    Uyeno ET
    Mod Probl Pharmacopsychiatry; 1978; 13():103-13. PubMed ID: 415228
    [No Abstract]   [Full Text] [Related]  

  • 13. A characteristic effect of hallucinogens on investigatory responding in rats.
    Geyer MA; Light RK; Rose GJ; Petersen LR; Horwitt DD; Adams LM; Hawkins RL
    Psychopharmacology (Berl); 1979 Sep; 65(1):35-40. PubMed ID: 116288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inescapable shock alters mescaline's disruption of active avoidance acquisition.
    Gibbons JL; Barr GA; Schimmel GT; Bridger WH
    Psychopharmacology (Berl); 1981; 74(4):336-8. PubMed ID: 6794077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mescaline treated rats attack immobile targets.
    Carder B; Sbordone R
    Pharmacol Biochem Behav; 1975; 3(5):923-5. PubMed ID: 1239776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives.
    Monte AP; Waldman SR; Marona-Lewicka D; Wainscott DB; Nelson DL; Sanders-Bush E; Nichols DE
    J Med Chem; 1997 Sep; 40(19):2997-3008. PubMed ID: 9301661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Resurgence of Hallucinogen Drugs in Clinical Research.
    Rivera-García MT; Cruz SL
    Rev Invest Clin; 2023; 75(3):169-178. PubMed ID: 37441761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the MDA and MDMA optical isomers in a stimulant-hallucinogen discrimination.
    Baker LE; Taylor MM
    Pharmacol Biochem Behav; 1997 Aug; 57(4):737-48. PubMed ID: 9259001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4- methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline.
    Callahan PM; Appel JB
    J Pharmacol Exp Ther; 1988 Sep; 246(3):866-70. PubMed ID: 2901488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Untreated rats develop "pathological" aggression when paired with a mescaline-treated rat in a shock-elicited aggression situation.
    Sbordone RJ; Garcia J
    Behav Biol; 1977 Dec; 21(4):451-61. PubMed ID: 564179
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.